Sep 21, 2021 | Drug and Device Corner, Drugs, Medical Devices
As part of the 2020 CARES Act, section 506J has been added to the FD&C Act. This section requires manufacturers of certain medical devices to report any interruption or permanent discontinuance in manufacturing to the CDRH. The list of relevant devices can be...
Sep 2, 2021 | Drugs, Seminar
Drug OTC GMPs and Labeling A Five-Part Virtual Seminar Series Presented by Lisa El-Shall, Victoria Pankovich, Jeb Hunter Tuesdays in June 2026 If you manufacture products in the OTC-drug space, including homeopathic, the challenges of FDA regulatory requirements...
Sep 1, 2021 | Cosmetics, Did You Know, Dietary Supplements, Drugs, Foods
Color additives for most FDA-regulated products (tobacco and some medical device products are exceptions) must be approved by FDA and listed in the Code of Federal Regulations. If a color additive isn’t listed, its approval must be petitioned and approved by FDA prior...
Aug 23, 2021 | Drug and Device Corner, Drugs, Medical Devices
FDA has announced most FY2022 user fee rates this month, conspicuously missing are the OMUFA 2022 user fee rates. We will continue to monitor Federal Register notices and share information as soon as it becomes available. Federal Register Vol. 86, No. 142 announcing...
Jul 28, 2021 | Drug and Device Corner, Drugs, Medical Devices
The FDA has planned a public webinar titled Manufacturing, Supply Chain, and Inspections during the COVID19 Public Health Emergency. Please follow the link to register for this webinar scheduled for 25 August 2021. Recently published in the Federal Register, FDA has...
Jul 13, 2021 | Drugs, Premium On Demand Webinar
Cleaning Validations – Your GMPs Depend on It An EAS Premium Webinar Presented by Joe McGuinness, EAS Independent Consultant. For FDA to require that equipment be clean prior to use is nothing new, with the main rationale to prevent contamination or adulteration of...